<unk>  refers to a regimen consisting of rituximab, mesna, ifosfamide, mitoxantrone, and etoposide used to treat relapsed or refractory Hodgkin's lymphoma and non-Hodgkin's lymphoma.
R-MINE regimen
TIP regimen
COPP regimen
EOX regimen
DCEP regimen
CNOP regimen
MOPP regimen
BEP regimen